Nissenson Allen
SEC insider (Form 3/4/5 filer). CIK 0001441889. Director at Elicio Therapeutics, Inc. (ELTX) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in BOSTON, MA.
Companies Nissenson Allen has filed insider reports for
- Elicio Therapeutics, Inc. (ELTX): Director
- ROCKWELL MEDICAL, INC. (RMTI): Director
Nissenson Allen
CIK: 0001441889
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 31, 2026ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
21.8K shares- - Jul 1, 2026RMTI
ROCKWELL MEDICAL, INC.
AwardDirect9.6K shares- - May 20, 2025RMTI
ROCKWELL MEDICAL, INC.
AwardDirect50K shares- - May 19, 2025ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
7.9K shares- - Nov 21, 2024ELTX
Elicio Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
4.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 |  ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 21,750 | - | - | Direct |
| Jul 1, 2026 |  RMTI ROCKWELL MEDICAL, INC. | Award | 9,633 | - | $0 | Direct |
| May 20, 2025 | RMTI ROCKWELL MEDICAL, INC. | Award | 50,000 | - | - | Direct |
| May 19, 2025 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 7,900 | - | - | Direct |
| Nov 21, 2024 | ELTX Elicio Therapeutics, Inc. | Award Stock Option (Right to Buy) | 4,100 | - | - | Direct |
1-5 of 5 transactions